Oncology

Supplementation with omega-3 or vitamin D may be useful for preventing and treating pain in patients with SCD. One study assessed the effects of supplementation in conjunction with standard therapy. A common clinical feature present in sickle cell disease (SCD) is pain caused by the distortion of red blood cells and the subsequent blocking of...

Children and youth with sickle cell disease (SCD) can benefit from digital interventions for self management of their disease. One study assessed the engagement and usefulness of a digital intervention in youth with SCD. Sickle cell disease (SCD) is marked by episodes of sudden, severe pain and increased risk for chronic pain. A digital platform...

Typically, monthly blood transfusion therapy is an option for children with sickle cell anemia (SCA) followed by hydroxyurea therapy. As blood transfusion therapy is not feasible in Africa, different strategies were investigated for stroke prevention in SCA. Stroke risk in children with sickle cell anemia (SCA) is 100 times times that for children without SCA,...

Advances in gene therapies and drug development have led to a resurgence in research for more effective sickle cell anemia treatments. This article discusses stem cell transplant options and avenues of drug development. Sickle cell anemia (SCA) results from a point mutation in the gene for the beta globin chain of hemglobin. After delivering oxygen,...

Like most of the medical issues in the 21st century, sickle-cell disease is also associated with a number of health disparities, some of which we highlight in this brief. Introduction Sickle-cell disease (SCD) is the most widely known hereditary illness across the globe, affecting roughly 100,000 persons in the United States, according to the Centers...

Advancements in genomics research have opened up new avenues of treatments for sickle cell disease. This article highlights some of the most promising innovative approaches. Sickle cell disease is a group of inherited blood disorders, the most commonly known of which is sickle cell anemia. The disease is caused by an amino acid substitution at...

Sickle cell disease is a complex and difficult condition to manage. A recent study has identified several socio-economic barriers that add to the clinical challenges of sickle cell disease, impeding timely and effective care and driving up healthcare costs. Introduction Sickle cell disease (SCD) is often associated with complications that lead to higher than normal...

Sickle cell disease (SCD) comes with an increased risk of health complications. Researchers have outlined steps the healthcare community can take to track and manage SCD. Even in the 21st century, sickle cell disease (SCD) is still regarded as a condition affected by health inequities. In a recent article in the journal Pediatrics, authors talked...

Funding and access to healthcare resources generally remain limited for people with sickle cell disease (SCD). The Indiana Sickle Cell Consortium launched a successful initiative to fund a program for assessing the needs of SCD patients. Adults with SCD continue to face a lack of funding and health care resources. The Indiana Sickle Cell Consortium...